Ignite Creation Date:
2025-12-24 @ 8:01 PM
Ignite Modification Date:
2026-02-03 @ 5:07 AM
Study NCT ID:
NCT03260504
Status:
TERMINATED
Last Update Posted:
2025-12-08
First Post:
2017-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer
Sponsor:
University of Washington
Organization: